Guidance rises again as revenue and investment activity accelerate

The quarter broadly met the core earnings bar, with a revenue upside. Published expectations called for roughly $0.51 of quarterly FFO per share and $150.1 million of revenue; CareTrust delivered $0.51 of Normalized FFO per share and $161.3 million of revenue. That makes the earnings result essentially in line, but revenue was about 7% above the published estimate.

The real positive is another guidance increase, not the quarter itself. Management lifted full-year Normalized FFO guidance to $2.03–$2.06 per share from the prior $2.00–$2.04 range, while Normalized FAD rose to $2.01–$2.04 from $1.98–$2.02. That is a modest increase from the immediately prior outlook, though the new midpoint of $2.045 is broadly around the existing published full-year expectation of approximately $2.06. (Increased Full Year 2026 Guidance; Guidance FY2026)

Growth is being funded by unusually heavy external investment. Year-to-date investments reached approximately $1.45 billion at an 8.7% blended stabilized yield, including $467.1 million of financing receivables and $332.8 million of loan funding. Q2 revenue rose 43% year over year, led by senior housing triple-net revenue up 78% and financing-receivable income up 305%. The trade-off is that this growth depends on continued access to equity and credit markets rather than solely on internal cash generation. (Company Snapshot; Investment Activity; Financial Highlights)

The balance sheet is much stronger on a pro forma basis, but reported debt is still rising. Net debt-to-annualized run-rate EBITDA improved to 1.01x from 2.0x a year earlier because of $577 million of expected forward-equity proceeds and higher earnings capacity. However, total debt increased to $1.21 billion from $900 million at the prior quarter-end, and the company subsequently drew another $285 million on its revolver. The leverage improvement therefore relies materially on unsettled equity forwards and the successful conversion of recent investments into earnings. (Net Debt to Annualized Normalized Run Rate EBITDA Reconciliation; Debt Summary)

The net read is modestly better than expected, with the signal concentrated in raised outlook and funding capacity. Quarterly Normalized FFO itself was in line rather than a beat, but revenue growth, a second consecutive guidance increase, a 76% payout ratio, and substantial liquidity support a slight positive interpretation. The main limitation is that the higher outlook largely reflects continued acquisitions and financing activity already assumed in the growth story, so this is reinforcement of the existing thesis—not a major change in expectations. (Financial Highlights; Increased Full Year 2026 Guidance; Company Snapshot)